Plexus (PLXS) Stock Forecast & Price Target

Plexus Corp has demonstrated a robust growth outlook, particularly in the Aerospace and Defense (A&D) segment, with an expected growth rate exceeding the previously targeted 9-12% for FY26, driven by solid demand in the Defense and Space subsectors. The Healthcare/Life Sciences sector also showed strong performance, achieving $466 million in revenue, representing a 10% quarter-over-quarter increase, aligning with the company's guidance for sequential growth. Overall, Plexus reported first-quarter revenue of $1.07 billion, a 9.6% year-over-year increase, further supported by positive expectations for revenue growth of 15.3% year-over-year in Q2 of FY26.

Plexus Corp reported a significant decline in free cash flow, dropping to $27 million year-over-year from $97.2 million, which raises concerns about cash generation capabilities amid a targeted goal of $100 million for the full fiscal year. The company's Industrial segment, accounting for 39.8% of revenue, experienced a contraction of 7.6% quarter-over-quarter and 3.6% year-over-year, reflecting broader economic pressures and potential demand shortfalls across major market verticals. Furthermore, key financial metrics such as return on invested capital (ROIC) decreased to 13.2%, down from 13.8%, while gross margin stagnated at 9.9%, indicating challenges in revenue generation and cost management that could hinder Plexus's competitive positioning in the market.